Indonesia Compression Therapy Market Report 2022 to 2030

Indonesia Compression Therapy Market Analysis

$ 3999

Indonesia's Compression Therapy Market was valued at $23 Mn in 2022 and is estimated to reach $35 Mn in 2030, exhibiting a CAGR of 5.6% during the forecast period. The increasing occurrence of venous disorders such as leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots is a major factor contributing to the expansion of the compression therapy market. Major participants in this sector include companies like Medtronic plc, Sigvaris, Bauerfeind, Juzo, McKesson Corporation, Cardinal Health, BSN Medical, Hartmann, Lohmann & Rauscher, and Molnlycke Health Care.

CATEGORY: Pharmaceuticals GEOGRAPHY: Indonesia AUTHOR: Medha Sansanwal

Buy Now

Indonesia Compression Therapy Market Executive Summary

Indonesia Compression Therapy Market was valued at $23 Mn in 2022 and is estimated to reach $35 Mn in 2030, exhibiting a CAGR of 5.6% during the forecast period.

Compression therapy, a medical procedure commonly used on limbs, aims to enhance blood circulation and reduce swelling. It is frequently employed for conditions like lymphedema, venous disorders, and specific edemas, with the primary goal of improving venous blood flow and preventing fluid buildup in tissues. Depending on the severity and individual needs, compression therapy may take various forms, such as elastic stockings, sleeves, or bandages. Techniques like compression wraps involve applying multiple layers for graduated compression, while intermittent pneumatic compression (IPC) mimics natural muscle contractions to aid venous return. Consulting with a healthcare provider is crucial to determine the most suitable technique and compression level, especially when developing comprehensive treatment plans for issues like poor circulation, swelling, or fluid retention.

In Indonesia, Chronic Venous Disease (CVD) presents a significant health concern, with a prevalence of approximately 26% for the C1 stage (visible varicose veins) and 8% for the C3 stage (skin changes and edema). Deep Vein Thrombosis (DVT) also poses a substantial risk, with a notably high incidence of 40.3%, suggesting a potentially higher prevalence compared to Western populations. Several factors contribute to the increased risk of these venous conditions in Indonesia. Rising obesity rates in the country may contribute to an elevated risk of CVD, while frequent childbearing, particularly common in certain regions, is identified as a risk factor for women. Lifestyle factors such as standing occupations, limited physical activity, and poor diet are likely contributors as well. Additionally, genetic predispositions within the Indonesian population could vary, further influencing susceptibility to venous conditions.

Compression therapy integration with telehealth platforms is a strategic approach toward improving patient convenience and access. Prominent corporations such as Bauerfeind and Juzo are actively participating in this endeavor, providing telehealth solutions that facilitate remote patient monitoring and assistance during compression therapy. This creative strategy offers a more individualized and patient-centred way to manage compression therapy, in line with the growing trend of digital health and adapting to changing patient needs.

Market Dynamics

Market Growth Drivers

Rising Prevalence of Venous Disorders: A significantly elevated rate of 40.3% for deep vein thrombosis (DVT) and the potential rise in chronic venous disease (CVD) attributed to lifestyle elements such as obesity and reduced physical activity. The expanding number of affected individuals is fuelling the need for compression therapy interventions.

Rising Geriatric Population: In 2022, Indonesia's senior citizen population comprises almost 19 Mn individuals, making up 9.6% of the overall population. Projections from the United Nations suggest that this figure is set to increase significantly, reaching 25% by 2050. The surge in demand for compression therapy in Indonesia is primarily fuelled by the aging demographic. The country is confronting the challenges posed by a swiftly growing elderly population, leading to a higher prevalence of conditions such as lymphedema, varicose veins, and cardiovascular diseases.

Increasing Healthcare Awareness: The increasing awareness among healthcare professionals and the general public about the benefits of compression therapy is propelling the market's growth. The market is growing as a result of educational initiatives, professional and athlete support, and other factors.

Market Restraints

High Cost of Products: Expensive compression garments, particularly from international brands, can be costly. For a significant segment of the populace, especially those with limited disposable income or those who depend on public healthcare programs, this could be an obstacle to access.

Low Patient Compliance: Consistently wearing compression apparel throughout the day may cause discomfort and restrictions, diminishing adherence and effectiveness of the treatment. This is particularly evident in non-medical scenarios such as sports recovery or daily wear. Insufficient patient education and awareness regarding the lasting advantages of compression therapy also play a role in fostering low compliance.

Lack of Insurance Coverage: Comprehensive insurance options for compression therapy are not widely accessible in Indonesia, thereby restricting patients' ability to receive treatment, particularly for preventive or extended durations.

Healthcare Policies and Regulatory Landscape

The National Agency of Drug and Food Control (Badan Pengawas Obat dan Makanan, or BPOM) and the Ministry of Health (Kemenkes) collaborate closely to control the pharmaceutical treatment landscape in Indonesia. To guarantee the effectiveness, safety, and quality of pharmaceutical marketing authorizations, BPOM plays a crucial role in their approval and oversight. The Ministry of Health provides overarching guidelines for healthcare, shaping the standards adhered to by these medications. The availability and payment processes for medicines are greatly impacted by the national health insurance program, Jaminan Kesehatan Nasional (JKN). Ongoing efforts to establish health technology assessment mechanisms and enact laws governing clinical trials and research also impact the review and approval processes in this regulatory environment.

Competitive Landscape

Key Players

Medtronic plc
Sigvaris
Bauerfeind
Juzo
McKesson Corporation
Cardinal Health
BSN Medical
Hartmann
Lohmann & Rauscher
Molnlycke Health Care

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Indonesia Compression Therapy Market Segmentation

By Product

Compression Bandages
Compression Wraps
Compression Stockings
Compression Tapes
Compression Pumps
Compression Braces
Other Compression Garments

By Technique

Static Compression Therapy
Dynamic Compression Therapy

By Application

Varicose Vein Treatment
Deep Vein Thrombosis Treatment
Lymphedema Treatment
Leg Ulcer Treatment
Other Applications

By Distribution Channel

Pharmacies and Retailers
Hospitals and Clinics
E-Commerce Platforms
Home Care Settings

Insights10 will provide you with the reports within 10 key parameters which are:

Market Overview
Market Growth Drivers & Restraints
Epidemiology of Disease Type
Market Segmentation
Market Share
Competitive Landscape
Key Company Profiles
Healthcare Policies & Regulatory Framework
Reimbursement Scenario
Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

Establishing market drivers and trends
Analyzing the regulatory landscape to understand future growth
Market Segment based analysis to obtain revenue/volume
Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.